
    
      Official Study Title: A randomized, double-blind study to evaluate the safety, tolerability,
      and pharmacokinetics of a supratherapeutic dose of GSK1349572 250 mg and a randomized,
      open-label study to evaluate the effects of omeprazole 40 mg daily and a high fat meal on the
      pharmacokinetics of GSK1349572 50 mg in healthy adult subjects (ING112941)
    
  